Avidin has expanded its Covid-19 molecular diagnostic portfolio to differentiate influenza virus A and B from Sars-Cov-2 virus with a PCR-based solution.
Avidin is able to differentiate between the two diseases with similar respiratory symptoms simultaneously, using a unique and high-sensitivity “multi-diagnostic” PCR solution from the same sample.
This solution can help you decide on vaccination programs, as patients with Sars-Cov-2, Influenza A, or Influenza B infection cannot receive influenza vaccination. Our PCR protocol is able to identify these from one sample, thus speeding up diagnosis.
6726 Szeged, Alső kikötó sor 11/D
1033 Budapest, Szentendrei út 95.